Clinical Trials

30 enrolled

CNS

Glioblastoma

NCT04088318 2024-03-04

NOVA-II

170 enrolled

Hand-Foot Skin Reaction (HFSR)

NCT04492293 2024-02-26

An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

115 enrolled

Genitourinary

Bladder Urothelial Cancer

NCT05178043 2024-02-22

GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma

5 enrolled

Carcinoma, Hepatocellular

NCT05135715 2024-02-20

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

50 enrolled

Dermatologic

Melanoma

NCT05297552 2024-02-20

A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Muscle Invasive Bladder Carcinoma

NCT05875428 2024-02-08

Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

104 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03549273 2024-02-07

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

62 enrolled

Gynecologic

Carcinoma, Uterine Cervical Dysplasia, Neoplasms, Neoplasms, Glandular and Epithelial

NCT06222125 2024-01-24

A Study of HB0025 Injection in Patients With Advanced Renal Cancer

100 enrolled

Genitourinary

Kidney Neoplasms

NCT04398524 2024-01-16

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

65 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03669718 2023-12-29

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

194 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04329429 2023-12-20

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

57 enrolled

Biliary Tract Neoplasms

NCT04965519 2023-12-18

A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies

120 enrolled

Gynecological Malignancy

NCT04089215 2023-11-24

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

82 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05329025 2023-11-24

A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05863325 2023-11-07

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05978739 2023-10-25

Evaluating Different Doses of Orelabrutinib in MCL

Lymphoma, Mantle-Cell

NCT04447183 2023-10-23

DTC

120 enrolled

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT06092606 2023-10-23

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

90 enrolled

Arrhythmias, Cardiac, Heart Failure, Neoplasms

NCT06089330 2023-10-18

A Study of JMT101 in Patients With Metastatic Colorectal Cancer

102 enrolled

Colorectal Neoplasms

NCT06074107 2023-10-11

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

128 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03420014 2023-10-10

FIBROSARC US

114 enrolled

Sarcoma

Leiomyosarcoma

NCT04362722 2023-10-10

DUNCAN

Dermatologic

Carcinoma, Carcinoma, Basal Cell

NCT04759664 2023-10-06

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

117 enrolled

EGFRI Induced Acneiform Lesions

NCT05329792 2023-10-06

IntriNSiC

70 enrolled

DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Sarcoma, Kaposi, Carcinoma, Merkel Cell

NCT04726215 2023-09-29

Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04165993 2023-09-21

Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer

68 enrolled

Breast Neoplasms

NCT05370235 2023-09-21

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

6 enrolled

Xeroderma Pigmentosum

NCT05353361 2023-09-15

A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer

402 enrolled

Breast Neoplasms

NCT06039202 2023-09-15

Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer

100 enrolled

Colorectal Neoplasms

NCT03447951 2023-09-13

OASES

33 enrolled

Carcinoma, Hepatocellular

NCT04262804 2023-08-22

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

123 enrolled

Breast Cancer Metastatic

NCT04984369 2023-08-21

The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment

50 enrolled

CRC

NCT03215693 2023-08-16

X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

152 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03961698 2023-08-14

MARIO-3

91 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT05658016 2023-08-14

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

24 enrolled

Head & NeckOther

Head and Neck Neoplasms, Mucositis

NCT05669521 2023-08-14

Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690

24 enrolled

GastrointestinalOther

Colorectal Neoplasms, Mucositis

NCT04297995 2023-08-08

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

131 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05127759 2023-08-08

The Efficacy and Safety of HLX208 in Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation

25 enrolled

Colorectal Neoplasms

NCT05979298 2023-08-07

Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer

Gynecologic

Ovarian Neoplasms

NCT04169347 2023-07-27

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

27 enrolled

Colorectal Cancer Metastatic

NCT05159752 2023-06-18

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

6 enrolled

Xeroderma Pigmentosum

NCT05191784 2023-06-12

GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients

20 enrolled

CNS

Glioblastoma

NCT05900219 2023-06-12

Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study

75 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03567720 2023-06-01

Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

65 enrolled

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT05233332 2023-05-31

mCRC

186 enrolled

Colorectal Neoplasms

NCT05263453 2023-05-31

HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation

104 enrolled

Dermatologic

Melanoma

NCT05823246 2023-05-26

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

DermatologicGenitourinary

66 enrolled

Carcinoma, Transitional Cell, Melanoma

NCT05527301 2023-05-25

HEM1036 Phase 2 Study in Low Anterior Resection Syndrome

67 enrolled